News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,232 Results
Type
Article (54950)
Company Profile (88)
Press Release (645860)
Multimedia
Podcasts (186)
Webinars (25)
Section
Business (217048)
Career Advice (3171)
Deals (34134)
Drug Delivery (170)
Drug Development (78188)
Employer Resources (187)
FDA (16458)
Job Trends (15332)
News (325710)
Policy (32179)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
Academia (2952)
Academic (1)
Accelerated approval (60)
ADA (49)
Adcomms (43)
Allergies (202)
Alliances (45629)
ALS (242)
Alzheimer's disease (2007)
Antibody-drug conjugate (ADC) (574)
Approvals (16866)
Artificial intelligence (819)
ASCO (338)
Autoimmune disease (373)
Automation (66)
Bankruptcy (340)
Best Places to Work (11964)
BIO (70)
BIOSECURE Act (23)
Biosimilars (253)
Biotechnology (67)
Bladder cancer (214)
Brain cancer (82)
Breast cancer (854)
Cancer (6678)
Cardiovascular disease (563)
Career advice (2717)
Career pathing (53)
CAR-T (390)
CDC (75)
Celiac Disease (2)
Cell therapy (1045)
Cervical cancer (59)
Clinical research (68664)
Collaboration (2341)
Commercialization (1)
Company closure (7)
Compensation (1554)
Complete response letters (112)
COVID-19 (2999)
CRISPR (121)
C-suite (1384)
Cystic fibrosis (161)
Data (8967)
Decentralized trials (3)
Denatured (52)
Depression (200)
Dermatology (107)
Diabetes (709)
Diagnostics (7283)
Digital health (65)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (398)
Drug pricing (242)
Drug shortages (39)
Duchenne muscular dystrophy (332)
Earnings (76727)
Editorial (81)
Employer branding (23)
Employer resources (167)
Events (106059)
Executive appointments (1240)
FDA (20654)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (21)
Frontotemporal dementia (36)
Funding (1943)
Gene editing (270)
Generative AI (72)
Gene therapy (841)
GLP-1 (1263)
Government (5341)
Grass and pollen (6)
Guidances (426)
Healthcare (19932)
Hematology (193)
HIV (102)
Huntington's disease (72)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (121)
Immunology and inflammation (344)
Immuno-oncology (120)
Indications (226)
Infectious disease (3402)
Inflammatory bowel disease (242)
Inflation Reduction Act (17)
Influenza (154)
Intellectual property (332)
Interviews (610)
IPO (16440)
IRA (60)
Job creations (3648)
Job search strategy (2198)
JPM (72)
Kidney cancer (25)
Labor market (111)
Layoffs (666)
Leadership (55)
Legal (7063)
Liver cancer (109)
Longevity (35)
Lung cancer (892)
Lymphoma (489)
Machine learning (67)
Management (66)
Manufacturing (1253)
Marketing (7)
MASH (228)
Medical affairs (1)
Medical device (14200)
Medtech (14387)
Mergers & acquisitions (19111)
Metabolic disorders (1827)
mRNA (273)
Multiple sclerosis (212)
NASH (24)
Neurodegenerative disease (531)
Neuropsychiatric disorders (130)
Neuroscience (3792)
Neurotech (1)
NextGen: Class of 2026 (6948)
Non-profit (4872)
Now hiring (61)
Obesity (866)
Opinion (373)
Ovarian cancer (245)
Pain (293)
Pancreatic cancer (369)
Parkinson's disease (419)
Partnered (36)
Patents (669)
Patient recruitment (830)
Peanut (69)
People (63587)
Pharmaceutical (27)
Pharmacy benefit managers (37)
Phase 1 (21063)
Phase 2 (30277)
Phase 3 (23135)
Pipeline (10409)
Policy (396)
Postmarket research (2367)
Preclinical (8898)
Press Release (69)
Prostate cancer (346)
Psychedelics (78)
Radiopharmaceuticals (376)
Rare diseases (1311)
Real estate (5604)
Recruiting (79)
Regulatory (26122)
Reports (53)
Research institute (2657)
Resumes & cover letters (498)
Rett syndrome (47)
RNA editing (26)
RSV (97)
Schizophrenia (197)
Series A (331)
Series B (247)
Service/supplier (4)
Sickle cell disease (132)
Special edition (32)
Spinal muscular atrophy (183)
Sponsored (53)
Startups (3530)
State (2)
Stomach cancer (19)
Supply chain (145)
Tariffs (99)
The Weekly (132)
Vaccines (1306)
Venture capital (134)
Weight loss (592)
Women's health (141)
Worklife (25)
Date
Today (106)
Last 7 days (468)
Last 30 days (1977)
Last 365 days (30899)
2026 (17582)
2025 (30546)
2024 (35272)
2023 (40030)
2022 (51173)
2021 (55642)
2020 (54845)
2019 (48448)
2018 (36793)
2017 (33263)
2016 (32238)
2015 (37212)
2014 (28233)
2013 (23317)
2012 (24926)
2011 (25555)
2010 (22465)
Location
Africa (955)
Alabama (102)
Alaska (7)
Arizona (322)
Arkansas (14)
Asia (41576)
Australia (7235)
California (13829)
Canada (4012)
China (1622)
Colorado (618)
Connecticut (610)
Delaware (429)
Europe (96275)
Florida (2115)
Georgia (457)
Hawaii (3)
Idaho (66)
Illinois (1176)
India (105)
Indiana (648)
Iowa (24)
Japan (618)
Kansas (137)
Kentucky (49)
Louisiana (58)
Maine (69)
Maryland (1660)
Massachusetts (9832)
Michigan (378)
Minnesota (783)
Mississippi (6)
Missouri (153)
Montana (35)
Nebraska (29)
Nevada (151)
New Hampshire (88)
New Jersey (3712)
New Mexico (34)
New York (3675)
North Carolina (1809)
North Dakota (11)
Northern California (6928)
Ohio (437)
Oklahoma (22)
Oregon (42)
Pennsylvania (2740)
Puerto Rico (33)
Rhode Island (50)
South America (1274)
South Carolina (90)
South Dakota (2)
Southern California (5589)
Tennessee (232)
Texas (2266)
United States (49215)
Utah (408)
Vermont (2)
Virginia (346)
Washington D.C. (79)
Washington State (1127)
West Virginia (4)
Wisconsin (144)
Wyoming (2)
701,232 Results for "marken formerly known as marken time critical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
June 1, 2026
·
5 min read
Press Releases
Moderna Recognized by TIME as One of the World’s Most Impactful Companies
May 13, 2026
·
2 min read
Press Releases
Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers
July 8, 2026
·
5 min read
Press Releases
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
July 14, 2026
·
10 min read
Regulatory
Amgen, AstraZeneca join FDA effort harnessing cloud for real-time clinical trials
The FDA’s real-time clinical trial mechanism allows drug sponsors to transmit data immediately to the regulator through the cloud—a system that could “compress drug development timelines,” Jefferies analysts said.
April 29, 2026
·
3 min read
·
Tristan Manalac
Opinion
Drug Price Critiques Ignore a Crucial Consideration—Time
Drug pricing criticism often fixates on a price at a single point in time but drug pricing is never static.
October 8, 2025
·
3 min read
·
Melanie Whittington
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
Press Releases
New funding opportunities pave the way for better diagnostics and treatment as well as for engineering efficient biosolutions and replacing critical and scarce resources
April 23, 2026
·
5 min read
COVID-19
CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup
The MIT professor of management, who already sits on the CDC’s revamped immunization advisory committee, is a known skeptic of vaccines, particularly mRNA technology.
August 26, 2025
·
2 min read
·
Tristan Manalac
Opinion
Local trade groups must support life sciences in these difficult times
As the industry faces policy changes and significant cuts to federal funding, local ecosystems can bolster companies through innovative resources to sustain growth and keep the U.S. at the center of biomedical innovation.
June 10, 2026
·
4 min read
·
Jennifer Hawks Bland
1 of 70,124
Next
